SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | ...

A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...

A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

Our sense of smell is more than just a way to enjoy food or detect dangers like fire. It turns out that changes in the ...

A D.C.-area doctor calls a new study on people who pack in only one or two days of exercise a week “empowering.” ...

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.

Have you ever heard of the “gut-brain connection”? It refers to the relationship between our gut microbiome and cognitive ...

Diabetes medications, specifically sodium-glucose cotransporter-2 (SGLT2) inhibitors, may be linked to a decreased risk of ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.